MEI Pharma, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
E MEI Pharma Signs Licensing Deal, Soars Higher
Article By: Terry Chrisomalis
Monday, August 8, 2016 10:42 PM EDT
The announcement of MEIP's license agreement with Swiss pharma group Helsinn put the stock up more than 48% premarket, ending the day up just shy of 28%.
In this article: MEIP
Read
Why MEI Pharma Is Likely To Rally Over $3 In The Next Month Or So
Video By: Scott Matusow
Thursday, May 7, 2015 11:10 AM EDT
In this video, I explain why I like the MEIP chart and why I think it will rally over $3 in the next 3 to 4 weeks .
In this video: MEIP Also: SGYP, IBB
Watch
MEI Pharma Is Oversold And Will Recover
Article By: Scott Matusow
Wednesday, April 1, 2015 12:02 PM EDT
Recently, MEI Pharma reported that its Phase II trial for Pracinostat in combination with azacitidine failed to meet its primary endpoint. However, Pracinostat has been shown to work in a 2nd line setting. With catalysts upcoming, the stock is oversold and half valued and should rally back.
In this article: MEIP, FOLD, ACAD
Read
MEI Pharma Stocks Plummet | Poor Trial Results To Blame
Article By: Joshua Rodriguez
Monday, March 23, 2015 1:09 PM EDT
MEI Pharma stocks are falling hard today after less than desirable testing results of proposed cancer drug show bad news.
In this article: MEIP
Read
Institutions Buying MEI Pharma Ahead Of Topline Data Catalyst In Mid-March
Article By: Scott Matusow
Wednesday, February 25, 2015 1:44 PM EDT
MEIP is expecting to release important Phase II topline data next month. We expect to see the stock price continue to increase up until that time. If positive as we expect, the stock should even rally further.
In this article: CELGZ, ONTX, CELG, MEIP
Read

PARTNER HEADLINES

Latest Tweets for $MEIP

No tweets yet!